Literature DB >> 8730294

Clinical, enzymatic, and molecular characterisation of a Portuguese family with a chronic form of GM2-gangliosidosis B1 variant.

M G Ribeiro1, T Sonin, R A Pinto, A Fontes, H Ribeiro, E Pinto, M M Palmeira, M C Sá Miranda.   

Abstract

Mutations in the hexosaminidase A gene (HEXA) causing the B1 variant of GM2-gangliosidosis result in the presence of a mutant enzyme protein with a catalytically defective alpha subunit. A rare and panethnically distributed mutation, transition G533A (Arg178His), is known to be a common allele among Portuguese patients with the subacute phenotype. We now report the presence of an Arg178His allele in three Portuguese sibs with a chronic form of the disease, who carry the transition G755A (Arg252His) on the second allele. This novel mutation is the first B1 allele to be associated with an adult phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730294      PMCID: PMC1050588          DOI: 10.1136/jmg.33.4.341

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Intermediate forms of human beta-N-acetylhexosaminidase lack activity towards 4-methylumbelliferyl beta-N-acetylglucosaminide 6-sulphate.

Authors:  T Beccari; C Emiliani; R Hosseini; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

2.  Mutation in GM2-gangliosidosis B1 variant.

Authors:  K Ohno; K Suzuki
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

3.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients.

Authors:  A Tanaka; K Ohno; K Sandhoff; I Maire; E H Kolodny; A Brown; K Suzuki
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

Review 4.  Juvenile GM2 gangliosidosis variant B1: clinical and biochemical study in seven patients.

Authors:  M Maia; D Alves; G Ribeiro; R Pinto; M C Sa Miranda
Journal:  Neuropediatrics       Date:  1990-02       Impact factor: 1.947

5.  The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.

Authors:  N Specola; M T Vanier; F Goutières; J Mikol; J Aicardi
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

6.  Human beta-hexosaminidase alpha chain: coding sequence and homology with the beta chain.

Authors:  R Myerowitz; R Piekarz; E F Neufeld; T B Shows; K Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Tay-Sachs disease: intron 7 splice junction mutation in two Portuguese patients.

Authors:  M G Ribeiro; R Pinto; M C Miranda; K Suzuki
Journal:  Biochim Biophys Acta       Date:  1995-01-25

8.  Molecular cloning of the cDNA which encodes beta-N-acetylhexosaminidase A from Dictyostelium discoideum. Complete amino acid sequence and homology with the human enzyme.

Authors:  T R Graham; H P Zassenhaus; A Kaplan
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

9.  GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene mutations in 11 patients from a defined region in Portugal.

Authors:  M R dos Santos; A Tanaka; M C sá Miranda; M G Ribeiro; M Maia; K Suzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.

Authors:  H J Kytzia; U Hinrichs; I Maire; K Suzuki; K Sandhoff
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  5 in total

Review 1.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

Review 2.  Chaperone therapy for GM2 gangliosidosis: effects of pyrimethamine on β-hexosaminidase activity in Sandhoff fibroblasts.

Authors:  Elena Chiricozzi; Natalia Niemir; Massimo Aureli; Alessandro Magini; Nicoletta Loberto; Alessandro Prinetti; Rosaria Bassi; Alice Polchi; Carla Emiliani; Catherine Caillaud; Sandro Sonnino
Journal:  Mol Neurobiol       Date:  2013-12-20       Impact factor: 5.590

3.  Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.

Authors:  Akemi Tanaka; Lan Thi Ngcok Hoang; Yasuaki Nishi; Satoshi Maniwa; Makio Oka; Tsunekazu Yamano
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

4.  Identification of novel variants in a large cohort of children with Tay-Sachs disease: An initiative of a multicentric task force on lysosomal storage disorders by Government of India.

Authors:  Mehul Mistri; Sanjeev Mehta; Dhaval Solanki; Mahesh Kamate; Neerja Gupta; Madhulika Kabra; Ratna Puri; Katta Girisha; Sankar Hariharan; Sheela Nampoothiri; Frenny Sheth; Jayesh Sheth
Journal:  J Hum Genet       Date:  2019-08-06       Impact factor: 3.172

5.  Genotype-phenotype correlation of gangliosidosis mutations using in silico tools and homology modeling.

Authors:  Li Ou; Sarah Kim; Chester B Whitley; Jeanine R Jarnes-Utz
Journal:  Mol Genet Metab Rep       Date:  2019-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.